- Clinical Trials Arena
Join Our Newsletter - Get important industry news and analysis sent to your inbox – sign up to our e-Newsletter here
X

Pfizer’s abrocitinib reduces flare in atopic dermatitis trial

Pfizer’s trial met both primary and secondary endpoints. Credit: Coolcaesar.